हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Newsletter
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Newsletter
Advertisement
X
News
Covovax
Covovax News
COVID-19
25 Jun 2022
Govt panel recommends emergency approval of SII’s Covovax for 7-11 year-olds
"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.
COVID-19
03 May 2022
Fourth wave: SII slashes price of each dose of Covovax jab, check details
SII has slashed the price of each dose of Covovax The price of each dose anti-Covid jab has been slashed from Rs 900 to Rs 225 SII CEO has said that Covovax is now available for children in India
Covovax
29 Apr 2022
NTAGI approves SII's covid vaccine Covovax for 12-17 age group: Sources
The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.
COVID-19
04 Apr 2022
Covovax makes it to Covid vaccine basket, proposed for all kids above 12
Covovax was approved by India's drug regulator for restricted use in emergency situations in adults on December 28. India began inoculating children aged 12-14 from March 16. Biological E's Corbevax is being used to inoculate them.
COVID-19 booster shot
23 Mar 2022
Covovax as booster dose: DCGI gives nod to phase-3 clinical trials
The vaccine has not been included in the country's inoculation programme against Covid-19 Covovax is manufactured by technology transfer from Novavax and is approved by European Medicines Agency for conditional marketing authorisation Many countries have been administering booster doses to their citizens, considering the uncertainties of the pandemic.
Novovax
23 Mar 2022
Novovax Covid-19 vaccine gets EUA nod for those aged between 12-18 yrs
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.
SII
09 Mar 2022
SII's ‘Covovax’ gets emergency use nod for children aged above 12 years
"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.
COVID-19 vaccine
04 Mar 2022
Covid-19 vaccine for 12-17 age group: Govt panel recommends EUA for Covovax
Covovax is Serum Institute of India's Covid-19 vaccine The recommendation of the Subject Expert Committee will be sent to the DCGI for approval India has so far been using Bharat Biotech's Covaxin to vaccinate adolescents between 15-18 years
Covovax
21 Feb 2022
Serum Institute seeks EUA for Covovax Covid-19 vaccine for 12-17 yrs age group
Covovax already has EUA for restricted use in emergency situations in adults on December 28 The government has not yet decided on vaccinating those aged below 15
corbevax
29 Dec 2021
Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines
Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.
Covovax
29 Dec 2021
Covovax authorisation is a vital step in India, says Novavax CEO
The Drugs Controller General of India (DCGI) has issued Emergency Use Authorization (EUA) for Covovax to prevent COVID-19 for adults 18 years old and above.
covid vaccine
28 Dec 2021
Corbevax and Covovax Vaccine Approved
2 vaccines and 1 drug related to corona have been approved. The Corbevax and Covovax vaccines have been approved.
corbevax
28 Dec 2021
India gets two more COVID-19 vaccines, CORBEVAX and COVOVAX receive EUA nod
Molnupiravir, an anti-viral drug, has also been approved for restricted use in an emergency situation.
Serum Institute of India
27 Dec 2021
CDSCO panel recommends emergency use authorisation for Covovax, Corbevax
The DCGI office had granted SII permission to manufacture and stock Covovax on May 17 The World Health Organisation had on December 17 issued emergency use listing for Covovax
Covovax
18 Dec 2021
Covovax gets emergency use approval
In view of the increasing threat of Omicron, WHO has approved the vaccine for children, Covovax
Serum Institute of India
17 Dec 2021
WHO approves Serum Institute's COVID vaccine, Covovax
Adar Poonawalla announced the news on Twitter The vaccine is named CovovaxTM
Covovax
28 Nov 2021
Covovax not approved in country of origin yet: Govt panel tells SII
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
COVID-19
01 Oct 2021
Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune
"Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here," said Dr Sanjay Lalwani.
Covovax
21 Aug 2021
Serum Institute files for WHO Emergency Use Listing for its Covovax vaccine
Serum Institute of India has filed for WHO emergency use listing for its upcoming COVID vaccine Covovax. The WHO has accepted the application of the Pune-based pharmaceutical company. A pre-submission meeting was also held on August 10.
Covovax
06 Aug 2021
Hope to launch Covovax vaccine for adults in October this year: SII CEO
Poonawala said he is hopeful that for adults Covovax will be launched in October, depending on DCGI approvals. It will be a two-dose vaccine and the price will be decided at the time of launch, he added. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.
1147477
1
1
Loading...
Trending news
DNA Video
DNA: Power Theft Allegations Against SP MP Ziaur Rahman Barq
DNA Video
DNA: Hot Tea Linked to Cancer Risk!
DNA Video
DNA: Why Jordan Fears After Syria’s Coup?
DNA Video
DNA: Gandhi Family Ruined My Career, says Mani Shankar Aiyar
DNA Video
DNA: NSA Ajit Doval’s China Visit - Inside Story
DNA Video
DNA: Ground Report- Tight Security Arrangements for Mahakumbh
DNA Video
DNA: Who got superstar Allu Arjun arrested?
DNA Video
DNA: US announces 100-point plan for Islamophobia
DNA Video
DNA: Revelation! Were rioters outsiders in Sambhal?
DNA Video
DNA: Why Muslims in UP Tracing Their Hindu Roots?
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK